Photos of searchers seeking victims of a Hiroshima bombing 80 years later on a nearby island
Because of poor medicine and care, only a few hundred were alive when the field hospital closed Aug. 25, according to historical records. They were buried in various locations in chaotic and rushed operations.
Decades later, people in the area are looking for the remains of the missing, driven by a desire to account for and honor the victims and bring relief to survivors who are still tormented by memories of missing loved ones.
Rebun Kayo, a Hiroshima University researcher, regularly visits Ninoshima to search for remains.
This is a photo gallery curated by AP photo editors.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Nutritionists warn that your matcha obsession could have this health drawback
The world has developed a thirst for matcha – a bright green Japanese drink that's sought after for its health benefits and caffeine. However, the drink of choice for many may have a downside. Not only is its popularity drying up global supplies, but drinking too much of it could contribute to an iron deficiency. Nutritionists warn the green lattes can affect iron absorption and vegetarians are at a higher risk than meat eaters. Matcha is made from the green tea plant, Camellia Sinensis, which is ground into a powder. Because it's grown in the shade the plant produces more chlorophyll, which not only gives it a deep green colour but also means it contains more nutrients. Rob Hobson, a nutritionist and author of Unprocess Your Family Life, explains the drink does have health benefits. 'It contains polyphenols which protects the body against oxidative damage. So, it helps to reduce inflammation which then helps to protect against chronic diseases,' he told the Independent. 'Because it contains caffeine it helps with mental focus. But it also contains L-theanine which helps to lessen that jittery edge that you get from caffeine,' he added. Research has also suggested these polyphenols in matcha can reduce the risk of heart disease. But the same health boosting polyphenols also make it harder for the body to absorb iron. Gunter Kuhnle, a professor of nutrition and food science at the University of Reading explained matcha tea can affect iron absorption by binding the (non-haem) iron that is found in many plant foods – such as lentils, leafy greens and tofu. 'It contains the compounds catechins and tannins – which are both polyphenols – that can bind to iron in the digestive tracts, and this stops them from being taken up by the body,' Professor Kuhnle told the Independent. 'These complexes then pass through the gut and are not useful for the body – this can reduce iron uptake by up to 50 per cent, but this varies a lot between individuals and depends on the timing of the meal and the type of food,' he added. He explained there is a similar problem with green tea because it also contains high levels of polyphenols. Although rare, in one instance a 48-year-old man became anaemic from excessive green tea consumption Professor Kuhnle said. Mr Hobson stressed that you don't need to worry if you have a balanced diet, but warned vegetarians are at a greater risk. That's because it only affects non-haem iron which is in tofu and lentils and not haem iron which is found in meat. 'If you are vegan or vegetarian and you are relying on lentils, leafy green and tofu for your iron, then you might want to avoid drinking matcha with your meals because it can inhibit iron absorption in the gut,' Mr Hobson said. He also stressed that if you are low in iron anyway and take iron supplements, you should avoid taking these at the same time as drinking a matcha. An iron deficiency, also called anaemia, can cause tiredness, shortness of breath, paler skin, headaches and heart palpitations, according to the NHS. Low iron is common among teenage girls, vegans and vegetarians with a study by Lund University in Sweden finding 38 per cent of participants who were teenage girls and 70 per cent of participants who were vegetarian or vegan, affected by the deficiency. If you want to reap the health benefits of matcha, in addition to not drinking it at mealtimes, make sure to avoid adding a lot of syrup or cream. Mr Hobson instead suggests the healthiest option is to drink it plain.
Entrepreneur
4 hours ago
- Entrepreneur
Quadria Group Appoints Namit Chugh as Director to Strengthen Health-tech Investment Focus
You're reading Entrepreneur India, an international franchise of Entrepreneur Media. HealthQuad, the healthcare-focused growth venture capital platform of Quadria Group, has appointed Namit Chugh as Director, marking a strategic move to bolster its investment approach in deep-tech and tech-enabled healthcare models. Chugh brings over 15 years of experience in healthtech investing and consulting. Welcoming the appointment, Dr Amit Varma, Co-founder of HealthQuad, said, "We are excited to welcome Namit to the HealthQuad team. His ability to identify and scale early-stage ventures with real-world healthcare impact aligns strongly with our mission. Namit brings fresh perspectives, deep sector insight, and a sharp founder-first mindset, qualities that will further strengthen our approach to identifying and nurturing the next wave of healthcare disruptors in India." Before joining HealthQuad, Chugh was Principal at W Health Ventures, an early-stage healthtech fund where he was part of the founding team. He played a central role in shaping the India and India–US corridor investment strategy, leading investments in companies such as Wysa, BeatO, and Mylo. He was also involved in the creation of 2070 Health, the venture studio arm of W Health Ventures, supporting tech-enabled companies at the seed stage and establishing India's only seed-to-venture healthtech platform. Earlier in his career, Chugh worked with Lok Capital, where he executed and exited investments across healthcare, consumer-tech, and insurtech, including Dr Mohan's Diabetes Center and Renewbuy. He also held roles at consulting firms Alvarez & Marsal and PwC, focusing on healthcare strategy and transaction advisory. At HealthQuad, Chugh will be responsible for identifying high-impact growth venture opportunities in areas such as artificial intelligence and other advanced technologies in healthcare, strengthening founder engagement, and driving thematic investment strategies. His appointment comes as HealthQuad expands its focus in high-growth sectors including healthtech, medtech, biopharma, and digitally enabled care. The expansion is supported by the recently launched HealthQuad Fund III, targeting up to USD 200 million with an additional USD 100 million option. Sunil Thakur, Co-founder of HealthQuad, noted, "Namit's track record of backing differentiated healthcare startups, combined with his operational rigor and ecosystem understanding, makes him a strong strategic addition to our leadership. His experience in cross-border models and thematic innovation will complement our vision as we double down on backing category-defining ventures in India and beyond." Reflecting on his new role, Chugh said, "Joining HealthQuad at this exciting phase is a natural next step in my journey of backing meaningful healthcare innovation. The team's conviction in supporting companies solving India's critical healthcare challenges resonates deeply with my own. I look forward to contributing towards building scalable, tech-enabled, and impactful healthcare models that improve access and outcomes for millions."
Associated Press
4 hours ago
- Associated Press
Extracellular Vesicles/Exosomes Asia Conference 2025 Discover Emerging Diagnostic and Therapeutic Applications of Extracellular Vesicles (Tokyo, Japan - October 6-7, 2025)
DUBLIN--(BUSINESS WIRE)--Aug 4, 2025-- The 'Extracellular Vesicles/Exosomes Asia 2025" conference has been added to offering. The Extracellular Vesicles/Exosomes Asia 2025 will be held October 6-7, 2025 right at Tokyo-Narita Airport, Japan. The Extracellular Vesicles/Exosomes Asia 2025 is Chaired by Professor Mei He from the University of Florida -- and brings together academics and industry/company participants from across Asia. Speakers for this conference from academic institutions, companies and technology/tools/instrumentation companies that provide the infrastructure and innovation in EV research tools development. Attendees and Exhibitors receive full access to both tracks for maximal scientific exchange and networking. Given the high levels of interest in Extracellular Vesicles/Exosomes across Asia from Research, Diagnostic and Therapeutics perspectives, this conference brings together the various stakeholders in this space for 2-days of intensive scientific presentations, product demonstrations as well as posters from students and postdoctoral fellows as a means to illustrate and disseminate their research. This is a 2-track conference composed of the following tracks: Agenda: Speakers For more information about this conference visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: JAPAN ASIA PACIFIC INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE PHARMACEUTICAL RESEARCH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 08/04/2025 07:34 AM/DISC: 08/04/2025 07:35 AM
